ALMR Alamar Biosciences, Inc.

Fundamentals / CIK 0002104204 / USD

Alamar Biosciences, Inc. reported $378.0M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALMR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for ALMR.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $33.55M $29.43M $26.04M $19.91M $16.16M $13.09M
Cost of Revenue $12.90M $11.71M $11.58M $8.02M $7.58M $6.70M
Gross Profit $20.64M $17.72M $14.46M $11.90M $8.58M $6.39M
Research & Development $16.17M $13.82M $13.02M $10.21M $8.89M $8.30M
Selling, General & Admin $19.62M $17.43M $13.79M $9.58M $7.61M $6.64M
Total Operating Expenses $35.78M $31.25M $26.80M $19.78M $16.50M $14.94M
Operating Income -$15.14M -$13.53M -$12.35M -$7.88M -$7.92M -$8.55M
EBITDA -$13.71M -$12.40M -$11.18M -$6.90M -$7.00M -$7.67M
Interest Income $2.17M $1.88M $539K $410K $630K $786K
Income Before Tax -$13.25M -$13.29M -$20.86M -$7.56M -$7.02M -$7.66M
Income Tax Expense $94K -$93K $464K $440K -- --
Net Income -$13.34M -$13.20M -$21.32M -$8.00M -$7.02M -$7.66M
Basic EPS -$0.19 -$0.22 -$1.74 -$0.69 -$0.62 -$0.68
Diluted EPS -$0.19 -$0.22 -$1.74 -$0.69 -$0.62 -$0.68
Basic Shares Outstanding 69.1M 58.7M 12.3M 11.6M 11.4M 11.3M
Diluted Shares Outstanding 69.1M 58.7M 12.3M 11.6M 11.4M 11.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for ALMR.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $121.5M $133.0M $64.59M $30.00M
Short-Term Investments $105.1M $117.1M $0 $0
Cash & Short-Term Investments $226.6M $250.1M $64.59M $30.00M
Accounts Receivable, Net $21.61M $20.34M $19.52M $12.75M
Inventory $54.13M $45.41M $39.93M $38.48M
Total Current Assets $317.7M $331.4M $141.5M $94.70M
Property, Plant & Equipment, Net $15.24M $13.36M $10.47M $10.50M
Long-Term Investments -- -- $0 $0
Other Non-Current Assets $2.51M $2.58M $2.09M $1.76M
Total Non-Current Assets $60.34M $59.59M $44.98M $45.29M
Total Assets $378.0M $391.0M $186.5M $140.0M
Accounts Payable $16.55M $13.79M $5.63M $5.87M
Deferred Revenue (Current) $1.78M $2.19M $2.11M $470K
Total Current Liabilities $33.48M $27.96M $24.05M $23.73M
Other Non-Current Liabilities $974K $1.03M $1.20M $599K
Total Non-Current Liabilities $40.84M $50.16M $105.5M $40.22M
Total Liabilities $74.32M $78.12M $129.5M $63.95M
Total Debt (incl. Leases) $42.35M $41.46M $30.58M $31.66M
Common Stock $7.0K $7.0K $1.0K $1.0K
Retained Earnings -$216.6M -$203.3M -$190.1M -$168.8M
Accumulated Other Comp. Income -$173K -$139K -$80K -$72K
Total Stockholders' Equity $303.7M $312.9M -$178.1M -$159.0M
Total Equity $303.7M -$312.9M -$178.1M -$159.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for ALMR.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$13.34M -$13.20M -$21.32M -$8.00M -$7.02M -$7.66M
Depreciation & Amortization $1.42M $1.13M $1.17M $983K $919K $888K
Stock-Based Compensation $3.92M $3.28M $1.47M $705K $680K $619K
Change in Receivables -$1.32M -$967K -$6.85M -$956K -$2.32M -$533K
Change in Inventory -$10.21M -$5.72M -$1.26M -$9.44M -$7.06M -$2.36M
Change in Payables $1.63M $6.32M $1.34M $3.22M -$1.81M $578K
Operating Cash Flow -$14.73M -$11.32M -$20.35M -$14.14M -$11.88M -$13.07M
Capital Expenditure -$463K -$3.64M -$600K -$1.22M -$753K -$554K
Free Cash Flow -$15.20M -$14.96M -$20.95M -$15.36M -$12.63M -$13.62M
Investing Cash Flow $11.74M -$120.8M -$778K $14.19M $17.95M $17.02M
Financing Cash Flow -$9.85M $201.8M $55.76M $10.40M $164K $243K
Net Change in Cash -$12.78M $69.73M $34.58M $9.98M $6.56M $4.33M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for ALMR.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 9.49x 11.85x 5.88x -- -- --
Quick Ratio 7.87x 10.23x 4.22x -- -- --
Debt to Equity 0.14x 0.13x -- -- -- --
Revenue Growth (YoY) +68.5% +82.1% +98.9% -- -- --
Gross Profit Growth (YoY) +73.5% +106.5% +126.3% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002104204) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal